Mycodern S.A.
Mycodern S.A., a technology company, engages in the provision of solutions for the collection of libraries and archives, materials for forensics, production of graphic media, sale of exhibition systems, and development of machinery technology for production systems in Poland. The company offers graphic media, including media, laminates, glues, berger fabric, and laminotrs; and libraries, such as … Read more
Mycodern S.A. (GY3) - Total Liabilities
Latest total liabilities as of September 2025: €3.35 Million EUR
Based on the latest financial reports, Mycodern S.A. (GY3) has total liabilities worth €3.35 Million EUR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Mycodern S.A. - Total Liabilities Trend (2021–2024)
This chart illustrates how Mycodern S.A.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Mycodern S.A. Competitors by Total Liabilities
The table below lists competitors of Mycodern S.A. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Daehan Green Power Corporation
KQ:060900
|
Korea | ₩11.26 Billion |
|
Powerhouse Ventures Ltd
AU:PVL
|
Australia | AU$2.05 Million |
|
Kadimastem Ltd
PINK:KMSTF
|
USA | $52.41 Million |
|
Fortuna Metals Limited
AU:FUN
|
Australia | AU$158.84K |
|
Ruchi Infrastructure Limited
NSE:RUCHINFRA
|
India | ₹1.14 Billion |
|
Jupiter Neurosciences, Inc. Common Stock
NASDAQ:JUNS
|
USA | $2.52 Million |
Liability Composition Analysis (2021–2024)
This chart breaks down Mycodern S.A.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.38 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.87 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.74 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Mycodern S.A.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Mycodern S.A. (2021–2024)
The table below shows the annual total liabilities of Mycodern S.A. from 2021 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €3.39 Million | -19.55% |
| 2023-12-31 | €4.22 Million | +1546.37% |
| 2022-12-31 | €256.17K | -- |
| 2021-12-31 | €0.00 | -- |